Other Briefings
Managing AI Slop: Why Due Diligence is Essential for Businesses Using Generative AI
Generative AI can produce convincing but false outputs. We explain why due diligence, verification, and governance are critical to managing AI slop.
Merchant Shipping Act, 2025: Insights for Trade & Logistics Businesses
In this article, India Briefing provides an overview of the Merchant Shipping Act, 2025, outlining key regulatory reforms, expanded vessel registration, strengthened safety standards, and their commercial implications for maritime and logistics operators.
Goa: Investment Outlook amid Tourism Revival, Sector Diversification
Goa’s 2025 investment landscape reflects steady diversification beyond tourism, with new project approvals and major PPP-led infrastructure commitments. For investors, the state offers expanding opportunities across tourism-linked services and niche industrial segments.
India Opens PLI Applications for Bulk Drug Manufacturing till December 26, 2025
India has launched a fresh round of production-linked incentive (PLI) applications for essential APIs such as meropenem and ritonavir to boost bulk drug manufacturing capacity. Eligible companies can apply from November 27 to December 26, 2025.
India Manufacturing Tracker 2025
Introducing the India Manufacturing Tracker 2025 by India Briefing—your go-to source for real-time updates on the country’s industrial production, emerging trends, and key sector insights.
India Expands Electronics Manufacturing Push with Second ECMS Approval Round
On November 17, 2025, India announced the second Electronics Components Manufacturing Scheme (ECMS) tranche with 17 new projects worth INR 71.72 billion, supporting high-value component production within the country.
India’s Design-Linked Scheme for the Semiconductor Sector: How Businesses Can Maximize Benefits
India’s DLI Scheme supports semiconductor startups and MSMEs by lowering design costs, enabling faster commercialization, and building IP-led growth. The program offers businesses a clear pathway to compete in high-value global semiconductor markets.
Eli Lilly’s Mounjaro Tops India’s Drug Sales – What It Reveals About the Country’s Health Market
Eli Lilly’s Mounjaro tops India’s drug sales, signaling a healthcare pivot toward obesity and diabetes management. See how it’s reshaping India’s pharma market.
